Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dagmar Fuhrer

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
The International Journal of Biochemistry & Cell Biology|November 15, 2011
Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroidKerstin Krause, Alexandra Boisnard, Christian Ihling, et al.
Endocrine-Related Cancer|August 1, 2025
Lenvatinib as salvage therapy in advanced and progressive GI-NETAnnie Mathew, Jaume Capdevila, Nicole Unger, et al.
BMC Cancer|April 17, 2015
Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational statusMartina Broecker-Preuss, Stefan Müller, Martin Britten, et al.
Thyroid : Official Journal of the American Thyroid Association|November 25, 2006
Toward the application of proteomics to human thyroid tissueKerstin Krause, Angelika Schierhorn, Andrea Sinz, et al.
European Thyroid Journal|January 4, 2022
2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?Furio Pacini, Dagmar Fuhrer, Rossella Elisei, et al.
International Journal of Endocrinology|April 16, 2015
Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary SyndromeSusanne Tan, Nils Vollmar, Sven Benson, et al.
Endocrine-Related Cancer|October 11, 2008
FOXO3a: a novel player in thyroid carcinogenesis?Stefan Karger, Carl Weidinger, Kerstin Krause, et al.
The Journal of Endocrinology|May 16, 2008
Evidence for a role of the amyloid precursor protein in thyroid carcinogenesisKerstin Krause, Stefan Karger, Sien-Yi Sheu, et al.
European Journal of Endocrinology|February 27, 2007
Characterisation of DEHAL1 expression in thyroid pathologiesKerstin Krause, Stefan Karger, Oliver Gimm, et al.
Journal of Molecular Endocrinology|February 15, 2012
Distinct pattern of oxidative DNA damage and DNA repair in follicular thyroid tumoursStefan Karger, Kerstin Krause, Cornelia Engelhardt, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
The International Journal of Biochemistry & Cell Biology|November 15, 2011
Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroidKerstin Krause, Alexandra Boisnard, Christian Ihling, et al.
Endocrine-Related Cancer|August 1, 2025
Lenvatinib as salvage therapy in advanced and progressive GI-NETAnnie Mathew, Jaume Capdevila, Nicole Unger, et al.
BMC Cancer|April 17, 2015
Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational statusMartina Broecker-Preuss, Stefan Müller, Martin Britten, et al.
Thyroid : Official Journal of the American Thyroid Association|November 25, 2006
Toward the application of proteomics to human thyroid tissueKerstin Krause, Angelika Schierhorn, Andrea Sinz, et al.
European Thyroid Journal|January 4, 2022
2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?Furio Pacini, Dagmar Fuhrer, Rossella Elisei, et al.
International Journal of Endocrinology|April 16, 2015
Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary SyndromeSusanne Tan, Nils Vollmar, Sven Benson, et al.
Endocrine-Related Cancer|October 11, 2008
FOXO3a: a novel player in thyroid carcinogenesis?Stefan Karger, Carl Weidinger, Kerstin Krause, et al.
The Journal of Endocrinology|May 16, 2008
Evidence for a role of the amyloid precursor protein in thyroid carcinogenesisKerstin Krause, Stefan Karger, Sien-Yi Sheu, et al.
European Journal of Endocrinology|February 27, 2007
Characterisation of DEHAL1 expression in thyroid pathologiesKerstin Krause, Stefan Karger, Oliver Gimm, et al.
Journal of Molecular Endocrinology|February 15, 2012
Distinct pattern of oxidative DNA damage and DNA repair in follicular thyroid tumoursStefan Karger, Kerstin Krause, Cornelia Engelhardt, et al.
Pageof 4